156 related articles for article (PubMed ID: 25903529)
1. New studies of low-molecular-weight heparin in pregnancy.
Middeldorp S
Thromb Res; 2015 Feb; 135 Suppl 1():S26-9. PubMed ID: 25903529
[TBL] [Abstract][Full Text] [Related]
2. Low-molecular-weight heparin to prevent recurrent venous thromboembolism in pregnancy: Rationale and design of the Highlow study, a randomised trial of two doses.
Bleker SM; Buchmüller A; Chauleur C; Ní Áinle F; Donnelly J; Verhamme P; Jacobsen AF; Ganzevoort W; Prins M; Beyer-Westendorf J; DeSancho M; Konstantinides S; Pabinger I; Rodger M; Decousus H; Middeldorp S
Thromb Res; 2016 Aug; 144():62-8. PubMed ID: 27289488
[TBL] [Abstract][Full Text] [Related]
3. A case series of LMWH use in pregnancy: should trough anti-Xa levels guide dosing?
Berresheim M; Wilkie J; Nerenberg KA; Ibrahim Q; Bungard TJ
Thromb Res; 2014 Dec; 134(6):1234-40. PubMed ID: 25450535
[TBL] [Abstract][Full Text] [Related]
4. ALIFE2 study: low-molecular-weight heparin for women with recurrent miscarriage and inherited thrombophilia--study protocol for a randomized controlled trial.
de Jong PG; Quenby S; Bloemenkamp KW; Braams-Lisman BA; de Bruin JP; Coomarasamy A; David M; DeSancho MT; van der Heijden OW; Hoek A; Hutten BA; Jochmans K; Koks CA; Kuchenbecker WK; Mol BW; Torrance HL; Scheepers HC; Stephenson MD; Verhoeve HR; Visser J; de Vries JI; Goddijn M; Middeldorp S
Trials; 2015 May; 16():208. PubMed ID: 25947329
[TBL] [Abstract][Full Text] [Related]
5. Obstetric complications and pregnancy-related venous thromboembolism: the effect of low-molecular-weight heparin on their prevention in carriers of factor V Leiden or prothrombin G20210A mutation.
Tormene D; Grandone E; De Stefano V; Tosetto A; Palareti G; Margaglione M; Castaman G; Rossi E; Ciminello A; Valdrè L; Legnani C; Tiscia GL; Bafunno V; Carraro S; Rodeghiero F; Simioni P
Thromb Haemost; 2012 Mar; 107(3):477-84. PubMed ID: 22273731
[TBL] [Abstract][Full Text] [Related]
6. Low-molecular-weight heparin plus aspirin versus aspirin alone in pregnant women with hereditary thrombophilia to improve live birth rate: meta-analysis of randomized controlled trials.
Areia AL; Fonseca E; Areia M; Moura P
Arch Gynecol Obstet; 2016 Jan; 293(1):81-86. PubMed ID: 26059084
[TBL] [Abstract][Full Text] [Related]
7. Pregnancy and venous thromboembolism.
Barco S; Nijkeuter M; Middeldorp S
Semin Thromb Hemost; 2013 Jul; 39(5):549-58. PubMed ID: 23633191
[TBL] [Abstract][Full Text] [Related]
8. Low-molecular-weight heparin for women with unexplained recurrent pregnancy loss: a multicenter trial with a minimization randomization scheme.
Schleussner E; Kamin G; Seliger G; Rogenhofer N; Ebner S; Toth B; Schenk M; Henes M; Bohlmann MK; Fischer T; Brosteanu O; Bauersachs R; Petroff D;
Ann Intern Med; 2015 May; 162(9):601-9. PubMed ID: 25938990
[TBL] [Abstract][Full Text] [Related]
9. The incidence and risk factors of recurrent venous thromboembolism during pregnancy.
Galambosi PJ; Ulander VM; Kaaja RJ
Thromb Res; 2014 Aug; 134(2):240-5. PubMed ID: 24835671
[TBL] [Abstract][Full Text] [Related]
10. Use of heparin in women with early and late miscarriages with and without thrombophilia.
Monien S; Kadecki O; Baumgarten S; Salama A; Dörner T; Kiesewetter H
Clin Appl Thromb Hemost; 2009 Dec; 15(6):636-44. PubMed ID: 19666941
[TBL] [Abstract][Full Text] [Related]
11. Adjustment of therapeutic LMWH to achieve specific target anti-FXa activity does not affect outcomes in pregnant patients with venous thromboembolism.
McDonnell BP; Glennon K; McTiernan A; O'Connor HD; Kirkham C; Kevane B; Donnelly JC; Ni Áinle F
J Thromb Thrombolysis; 2017 Jan; 43(1):105-111. PubMed ID: 27517381
[TBL] [Abstract][Full Text] [Related]
12. The use of low-molecular-weight heparin for the management of venous thromboembolism in pregnancy.
Eldor A
Eur J Obstet Gynecol Reprod Biol; 2002 Aug; 104(1):3-13. PubMed ID: 12128275
[TBL] [Abstract][Full Text] [Related]
13. The management of thrombosis in pregnancy: role of low-molecular-weight heparin.
Kher A; Bauersachs R; Nielsen JD
Thromb Haemost; 2007 Apr; 97(4):505-13. PubMed ID: 17393011
[TBL] [Abstract][Full Text] [Related]
14. Safety of therapeutic doses of tinzaparin during pregnancy.
Parent F; Deruelle P; Sanchez O; Meyer G; Girard P; Jilwan F; Boyer-Neumann C; Wolf M; Simonneau G
Gynecol Obstet Invest; 2015; 79(4):256-62. PubMed ID: 25896030
[TBL] [Abstract][Full Text] [Related]
15. Antiphospholipid antibodies associated with recurrent pregnancy loss: prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin.
Noble LS; Kutteh WH; Lashey N; Franklin RD; Herrada J
Fertil Steril; 2005 Mar; 83(3):684-90. PubMed ID: 15749498
[TBL] [Abstract][Full Text] [Related]
16. Long-term use of different doses of low-molecular-weight heparin versus vitamin K antagonists in the treatment of venous thromboembolism.
Romera-Villegas A; Cairols-Castellote MA; Vila-Coll R; Martí-Mestre X; Colomé E; Iguaz I
Ann Vasc Surg; 2010 Jul; 24(5):628-39. PubMed ID: 19932949
[TBL] [Abstract][Full Text] [Related]
17. [Thromboembolism and antithrombotic management in pregnancy].
Pajor A
Orv Hetil; 2011 May; 152(21):815-21. PubMed ID: 21546339
[TBL] [Abstract][Full Text] [Related]
18. The prevention and treatment of venous thromboembolism in pregnancy.
Villani M; Ageno W; Grandone E; Dentali F
Expert Rev Cardiovasc Ther; 2017 May; 15(5):397-402. PubMed ID: 28425765
[TBL] [Abstract][Full Text] [Related]
19. Clinical inquiries: should you test or treat pregnant women with a history of pregnancy-related VTE?
Crotteau CA; Kovach F
J Fam Pract; 2013 Apr; 62(4):206-7. PubMed ID: 23570034
[No Abstract] [Full Text] [Related]
20. The management of antenatal venous thromboembolism in the UK and Ireland: a prospective multicentre observational survey.
Voke J; Keidan J; Pavord S; Spencer NH; Hunt BJ;
Br J Haematol; 2007 Nov; 139(4):545-58. PubMed ID: 17916101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
